BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10494511)

  • 1. Chemotherapy in head and neck cancer. Overview of newer agents.
    Khattab J; Urba SG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):753-68. PubMed ID: 10494511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the taxoids and other new agents in head and neck cancer therapy.
    Schrijvers D; Vermorken JB
    Curr Opin Oncol; 1998 May; 10(3):233-41. PubMed ID: 9619360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions.
    Khuri FR; Shin DM; Glisson BS; Lippman SM; Hong WK
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):25-33. PubMed ID: 10952435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New cytostatic agents for the treatment of head and neck cancer.
    Devriendt D; Klastersky J
    Acta Otorhinolaryngol Belg; 1997; 51(2):61-8. PubMed ID: 9241369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising new agents in the treatment of non-small cell lung cancer.
    Edelman MJ; Gandara DR
    Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
    Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization with chemotherapeutic agents.
    Caffo O
    Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?
    Brockstein B
    Curr Opin Oncol; 2000 May; 12(3):221-8. PubMed ID: 10841194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New chemotherapeutic agents for non-small cell lung cancer.
    Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
    Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Palliative chemotherapy of head and neck cancer: present status and future development].
    Hennemann B
    Laryngorhinootologie; 2006 Mar; 85(3):172-8. PubMed ID: 16547892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of radiation, with or without chemotherapy, in the management of NSCLC.
    Chakravarthy A; Johnson D; Choy H
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):93-100. PubMed ID: 10550832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
    Bunn PA; Kelly K
    Clin Cancer Res; 1998 May; 4(5):1087-100. PubMed ID: 9607565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New chemotherapy agents for small cell lung cancer.
    Kelly K
    Chest; 2000 Apr; 117(4 Suppl 1):156S-162S. PubMed ID: 10777472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New wave of chemotherapeutic agents: update in pulmonary oncology].
    Sculier JP
    Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
    [No Abstract]   [Full Text] [Related]  

  • 16. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
    Ferrigno D; Buccheri G
    Lung Cancer; 2000 Aug; 29(2):91-104. PubMed ID: 10963840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs for treating small cell lung cancer.
    Ettinger DS
    Lung Cancer; 1995 Jun; 12 Suppl 3():S53-61. PubMed ID: 7551957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix.
    Paton F; Paulden M; Saramago P; Manca A; Misso K; Palmer S; Eastwood A
    Health Technol Assess; 2010 May; 14 Suppl 1():55-62. PubMed ID: 20507804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New agents in the treatment of small cell lung cancer.
    Ghaemmaghami M; Jett JR
    Chest; 1998 Jan; 113(1 Suppl):86S-91S. PubMed ID: 9438696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.